Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska
{"title":"肝硬化患者的存活率:前瞻性研究","authors":"Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska","doi":"10.2478/prilozi-2023-0045","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: The differences in the survival time of cirrhotic patients reported by different studies are probably caused by the influence of many contributing factors. The aim of the study was to evaluate the survival over a one-year period, to register the occurrence of acute decompensation (AD) and to determine the most frequent causes of death. <b>Material and methods</b>: Out of 71 patients enrolled in the study, 63 completed the prospective one-year follow-up. During the follow-up, we evaluated the occurrence of AD, the causes of death, and we registered three-month, six-month and one-year survival regarding the AD status at presentation. <b>Results</b>: Of the 63 patients, 24 (38.09%) died before the end of the study (14 patients before the end of three months, 6 before the end of six months and 4 patients before the end of one year). The overall survival was 38.09% and the mean survival time was 108 ± 98.53 days. The most prevalent cause of death was bleeding from esophageal varices (5 patients, 20.83%). AD patients had a significantly shorter survival than patients without AD (97±90.54 vs. 229±138.59) and 78.57% of them died during the follow-up. The estimated six-month and one-year median survival time were 272.8 [95% CI (238.4-307.2)] and 267.1 [95% CI (232.9-301.2)] days, respectively. The six-month and one-year survival were significantly shorter in AD patients (p<0.0001). <b>Conclusion</b>: The etiology, stage of liver disease and the presence of AD are important factors that influence on the survival in cirrhotic patients.</p>","PeriodicalId":74492,"journal":{"name":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","volume":"44 3","pages":"41-47"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Survival in Patients with Liver Cirrhosis: A Prospective Study.\",\"authors\":\"Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska\",\"doi\":\"10.2478/prilozi-2023-0045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction</b>: The differences in the survival time of cirrhotic patients reported by different studies are probably caused by the influence of many contributing factors. The aim of the study was to evaluate the survival over a one-year period, to register the occurrence of acute decompensation (AD) and to determine the most frequent causes of death. <b>Material and methods</b>: Out of 71 patients enrolled in the study, 63 completed the prospective one-year follow-up. During the follow-up, we evaluated the occurrence of AD, the causes of death, and we registered three-month, six-month and one-year survival regarding the AD status at presentation. <b>Results</b>: Of the 63 patients, 24 (38.09%) died before the end of the study (14 patients before the end of three months, 6 before the end of six months and 4 patients before the end of one year). The overall survival was 38.09% and the mean survival time was 108 ± 98.53 days. The most prevalent cause of death was bleeding from esophageal varices (5 patients, 20.83%). AD patients had a significantly shorter survival than patients without AD (97±90.54 vs. 229±138.59) and 78.57% of them died during the follow-up. The estimated six-month and one-year median survival time were 272.8 [95% CI (238.4-307.2)] and 267.1 [95% CI (232.9-301.2)] days, respectively. The six-month and one-year survival were significantly shorter in AD patients (p<0.0001). <b>Conclusion</b>: The etiology, stage of liver disease and the presence of AD are important factors that influence on the survival in cirrhotic patients.</p>\",\"PeriodicalId\":74492,\"journal\":{\"name\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"volume\":\"44 3\",\"pages\":\"41-47\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2478/prilozi-2023-0045\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/prilozi-2023-0045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言不同研究报告中肝硬化患者存活时间的差异可能是由多种因素造成的。本研究旨在评估肝硬化患者一年内的存活率,登记急性失代偿(AD)的发生率,并确定最常见的死亡原因。材料和方法在 71 名参与研究的患者中,63 人完成了为期一年的前瞻性随访。在随访期间,我们评估了急性失代偿的发生率、死亡原因,并登记了与发病时急性失代偿状态有关的三个月、六个月和一年的存活率。结果显示63 名患者中有 24 人(38.09%)在研究结束前死亡(14 人在三个月前死亡,6 人在六个月前死亡,4 人在一年前死亡)。总存活率为 38.09%,平均存活时间为 108 ± 98.53 天。最常见的死亡原因是食道静脉曲张出血(5 名患者,20.83%)。AD 患者的生存期明显短于无 AD 患者(97±90.54 对 229±138.59),其中 78.57% 的患者在随访期间死亡。估计的六个月和一年中位生存时间分别为 272.8 [95% CI (238.4-307.2)] 天和 267.1 [95% CI (232.9-301.2)] 天。AD患者的6个月和1年存活期明显更短(p结论:病因、肝病阶段和 AD 的存在是影响肝硬化患者存活率的重要因素。
Survival in Patients with Liver Cirrhosis: A Prospective Study.
Introduction: The differences in the survival time of cirrhotic patients reported by different studies are probably caused by the influence of many contributing factors. The aim of the study was to evaluate the survival over a one-year period, to register the occurrence of acute decompensation (AD) and to determine the most frequent causes of death. Material and methods: Out of 71 patients enrolled in the study, 63 completed the prospective one-year follow-up. During the follow-up, we evaluated the occurrence of AD, the causes of death, and we registered three-month, six-month and one-year survival regarding the AD status at presentation. Results: Of the 63 patients, 24 (38.09%) died before the end of the study (14 patients before the end of three months, 6 before the end of six months and 4 patients before the end of one year). The overall survival was 38.09% and the mean survival time was 108 ± 98.53 days. The most prevalent cause of death was bleeding from esophageal varices (5 patients, 20.83%). AD patients had a significantly shorter survival than patients without AD (97±90.54 vs. 229±138.59) and 78.57% of them died during the follow-up. The estimated six-month and one-year median survival time were 272.8 [95% CI (238.4-307.2)] and 267.1 [95% CI (232.9-301.2)] days, respectively. The six-month and one-year survival were significantly shorter in AD patients (p<0.0001). Conclusion: The etiology, stage of liver disease and the presence of AD are important factors that influence on the survival in cirrhotic patients.